Fidelity Investments
NKTR icon

Fidelity Investments’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$395K Sell
15,276
-218,688
-93% -$5.65M ﹤0.01% 3058
2025
Q1
$159K Sell
233,964
-280,400
-55% -$191K ﹤0.01% 3342
2024
Q4
$478K Buy
514,364
+127,708
+33% +$119K ﹤0.01% 2945
2024
Q3
$503K Buy
386,656
+309,822
+403% +$403K ﹤0.01% 2852
2024
Q2
$95.3K Sell
76,834
-48,611
-39% -$60.3K ﹤0.01% 3312
2024
Q1
$117K Sell
125,445
-1,218
-1% -$1.14K ﹤0.01% 3212
2023
Q4
$71.6K Buy
126,663
+50,028
+65% +$28.3K ﹤0.01% 3355
2023
Q3
$45.6K Sell
76,635
-251,522
-77% -$150K ﹤0.01% 3408
2023
Q2
$189K Sell
328,157
-103,279
-24% -$59.4K ﹤0.01% 2970
2023
Q1
$303K Buy
431,436
+3,838
+0.9% +$2.7K ﹤0.01% 2849
2022
Q4
$966K Sell
427,598
-33,840
-7% -$76.5K ﹤0.01% 2553
2022
Q3
$1.48M Buy
461,438
+270,100
+141% +$864K ﹤0.01% 2512
2022
Q2
$727K Sell
191,338
-58,534
-23% -$222K ﹤0.01% 2749
2022
Q1
$1.35M Sell
249,872
-6,509,332
-96% -$35.1M ﹤0.01% 2714
2021
Q4
$91.3M Sell
6,759,204
-7,248,541
-52% -$97.9M 0.01% 1136
2021
Q3
$252M Sell
14,007,745
-1,840,557
-12% -$33.1M 0.02% 707
2021
Q2
$272M Sell
15,848,302
-1,986,080
-11% -$34.1M 0.02% 690
2021
Q1
$357M Sell
17,834,382
-1,115,303
-6% -$22.3M 0.03% 554
2020
Q4
$322M Sell
18,949,685
-609,112
-3% -$10.4M 0.03% 550
2020
Q3
$324M Buy
19,558,797
+377,580
+2% +$6.26M 0.03% 442
2020
Q2
$444M Sell
19,181,217
-333,673
-2% -$7.73M 0.05% 349
2020
Q1
$348M Buy
19,514,890
+4,576,864
+31% +$81.7M 0.05% 339
2019
Q4
$322M Buy
14,938,026
+1,807,990
+14% +$39M 0.04% 460
2019
Q3
$239M Sell
13,130,036
-5,523,213
-30% -$101M 0.03% 566
2019
Q2
$664M Sell
18,653,249
-1,773,645
-9% -$63.1M 0.08% 253
2019
Q1
$686M Sell
20,426,894
-5,534,626
-21% -$186M 0.08% 239
2018
Q4
$853M Buy
25,961,520
+2,041,954
+9% +$67.1M 0.12% 152
2018
Q3
$1.46B Sell
23,919,566
-1,786,336
-7% -$109M 0.16% 114
2018
Q2
$1.26B Buy
25,705,902
+1,608,834
+7% +$78.6M 0.14% 136
2018
Q1
$2.56B Buy
24,097,068
+12,854,106
+114% +$1.37B 0.3% 52
2017
Q4
$671M Buy
11,242,962
+10,717,509
+2,040% +$640M 0.08% 270
2017
Q3
$12.6M Buy
525,453
+31,750
+6% +$762K ﹤0.01% 1863
2017
Q2
$9.65M Sell
493,703
-1,453,941
-75% -$28.4M ﹤0.01% 1955
2017
Q1
$45.7M Buy
1,947,644
+580,341
+42% +$13.6M 0.01% 1344
2016
Q4
$16.8M Sell
1,367,303
-763,800
-36% -$9.37M ﹤0.01% 1750
2016
Q3
$36.6M Buy
2,131,103
+752,200
+55% +$12.9M ﹤0.01% 1433
2016
Q2
$19.6M Sell
1,378,903
-174,600
-11% -$2.48M ﹤0.01% 1689
2016
Q1
$21.4M Sell
1,553,503
-156,300
-9% -$2.15M ﹤0.01% 1631
2015
Q4
$28.8M Hold
1,709,803
﹤0.01% 1502
2015
Q3
$18.7M Hold
1,709,803
﹤0.01% 1680
2015
Q2
$21.4M Hold
1,709,803
﹤0.01% 1703
2015
Q1
$18.8M Hold
1,709,803
﹤0.01% 1748
2014
Q4
$26.5M Buy
1,709,803
+1,106,900
+184% +$17.2M ﹤0.01% 1617
2014
Q3
$7.28M Buy
+602,903
New +$7.28M ﹤0.01% 2109
2013
Q4
Sell
-119,300
Closed -$1.25M 2663
2013
Q3
$1.25M Sell
119,300
-107,800
-47% -$1.13M ﹤0.01% 2420
2013
Q2
$2.62M Buy
+227,100
New +$2.62M ﹤0.01% 2274